CERS
Price
$1.65
Change
-$0.09 (-5.17%)
Updated
Feb 21 closing price
Capitalization
342.62M
67 days until earnings call
UTMD
Price
$60.20
Change
-$0.57 (-0.94%)
Updated
Feb 21 closing price
Capitalization
255.21M
Ad is loading...

CERS vs UTMD

Header iconCERS vs UTMD Comparison
Open Charts CERS vs UTMDBanner chart's image
Cerus
Price$1.65
Change-$0.09 (-5.17%)
Volume$3.46M
Capitalization342.62M
Utah Medical Products
Price$60.20
Change-$0.57 (-0.94%)
Volume$14.92K
Capitalization255.21M
CERS vs UTMD Comparison Chart
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. UTMD commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and UTMD is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CERS: $1.86 vs. UTMD: $61.14)
Brand notoriety: CERS and UTMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 73% vs. UTMD: 63%
Market capitalization -- CERS: $342.62M vs. UTMD: $255.21M
CERS [@Medical Specialties] is valued at $342.62M. UTMD’s [@Medical Specialties] market capitalization is $255.21M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileUTMD’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • UTMD’s FA Score: 1 green, 4 red.
According to our system of comparison, UTMD is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 6 TA indicator(s) are bullish while UTMD’s TA Score has 4 bullish TA indicator(s).

  • CERS’s TA Score: 6 bullish, 4 bearish.
  • UTMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CERS is a better buy in the short-term than UTMD.

Price Growth

CERS (@Medical Specialties) experienced а +10.71% price change this week, while UTMD (@Medical Specialties) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.56%. For the same industry, the average monthly price growth was -1.17%, and the average quarterly price growth was +2.64%.

Reported Earning Dates

CERS is expected to report earnings on May 01, 2025.

UTMD is expected to report earnings on Jan 28, 2025.

Industries' Descriptions

@Medical Specialties (-1.56% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CERS($343M) has a higher market cap than UTMD($255M). CERS YTD gains are higher at: 20.779 vs. UTMD (-0.537). UTMD has higher annual earnings (EBITDA): 23.1M vs. CERS (-26.34M). UTMD has more cash in the bank: 92.9M vs. CERS (65.9M). UTMD has less debt than CERS: UTMD (295K) vs CERS (96M). CERS has higher revenues than UTMD: CERS (156M) vs UTMD (50.2M).
CERSUTMDCERS / UTMD
Capitalization343M255M135%
EBITDA-26.34M23.1M-114%
Gain YTD20.779-0.537-3,871%
P/E RatioN/A15.45-
Revenue156M50.2M311%
Total Cash65.9M92.9M71%
Total Debt96M295K32,542%
FUNDAMENTALS RATINGS
CERS vs UTMD: Fundamental Ratings
CERS
UTMD
OUTLOOK RATING
1..100
164
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9761
PRICE GROWTH RATING
1..100
5774
P/E GROWTH RATING
1..100
10058
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTMD's Valuation (13) in the Medical Specialties industry is in the same range as CERS (45). This means that UTMD’s stock grew similarly to CERS’s over the last 12 months.

UTMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CERS (100). This means that UTMD’s stock grew similarly to CERS’s over the last 12 months.

UTMD's SMR Rating (61) in the Medical Specialties industry is somewhat better than the same rating for CERS (97). This means that UTMD’s stock grew somewhat faster than CERS’s over the last 12 months.

CERS's Price Growth Rating (57) in the Medical Specialties industry is in the same range as UTMD (74). This means that CERS’s stock grew similarly to UTMD’s over the last 12 months.

UTMD's P/E Growth Rating (58) in the Medical Specialties industry is somewhat better than the same rating for CERS (100). This means that UTMD’s stock grew somewhat faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSUTMD
RSI
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 6 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
77%
Bearish Trend 6 days ago
67%
Momentum
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 6 days ago
65%
MACD
ODDS (%)
Bearish Trend 6 days ago
83%
Bullish Trend 6 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
78%
Bearish Trend 6 days ago
46%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 13 days ago
56%
Declines
ODDS (%)
Bearish Trend 17 days ago
83%
Bearish Trend 17 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
78%
Bullish Trend 6 days ago
69%
Aroon
ODDS (%)
Bullish Trend 6 days ago
80%
Bearish Trend 6 days ago
56%
View a ticker or compare two or three
Ad is loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with LAB. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+0.54%
LAB - CERS
42%
Loosely correlated
-0.71%
ILMN - CERS
41%
Loosely correlated
+0.85%
ICUI - CERS
41%
Loosely correlated
+2.05%
FLGT - CERS
40%
Loosely correlated
-0.12%
MASS - CERS
40%
Loosely correlated
-1.08%
More

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with AKYA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then AKYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
+0.15%
AKYA - UTMD
36%
Loosely correlated
-7.79%
LIVN - UTMD
34%
Loosely correlated
-0.99%
BLCO - UTMD
33%
Loosely correlated
-0.37%
CERS - UTMD
33%
Loosely correlated
+0.54%
MDT - UTMD
33%
Poorly correlated
-7.26%
More